Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Share-based Compensation (2016 - 2025)

Sensus Healthcare has reported Share-based Compensation over the past 10 years, most recently at $76000.0 for Q4 2025.

  • Quarterly results put Share-based Compensation at $76000.0 for Q4 2025, up 138.19% from a year ago — trailing twelve months through Dec 2025 was $160000.0 (up 181.22% YoY), and the annual figure for FY2025 was $295000.0, up 14650.0%.
  • Share-based Compensation for Q4 2025 was $76000.0 at Sensus Healthcare, up from $5000.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for SRTS hit a ceiling of $204000.0 in Q3 2021 and a floor of -$199000.0 in Q4 2024.
  • Median Share-based Compensation over the past 5 years was $46000.0 (2022), compared with a mean of $25437.5.
  • Biggest five-year swings in Share-based Compensation: plummeted 482.69% in 2024 and later skyrocketed 7800.0% in 2025.
  • Sensus Healthcare's Share-based Compensation stood at $90000.0 in 2021, then crashed by 252.22% to -$137000.0 in 2022, then skyrocketed by 137.96% to $52000.0 in 2023, then plummeted by 482.69% to -$199000.0 in 2024, then soared by 138.19% to $76000.0 in 2025.
  • The last three reported values for Share-based Compensation were $76000.0 (Q4 2025), $5000.0 (Q2 2025), and $79000.0 (Q1 2025) per Business Quant data.